Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes

por Apollinariya V. Bogolyubova, Alexander Y. Mayorov, Ekaterina E. Mishina, Anton M. Schwartz, Pavel V. Belousov
Publicado 2017

Nonalcoholic fatty liver disease: cause or consequence of insulin resistance?

por Ekaterina E. Mishina, Alexander Y. Mayorov, Pavel O. Bogomolov, Maria V. Matsievich, Ksenia Y. Kokina, Apollinariya V. Bogolyubova
Publicado 2017